News|Articles|January 2, 2018

Enhancing the Solubility of Poorly Soluble Drugs

External Link - PT1217Dow-BrockhagenFCpr3fWeb.pdf

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

JIN-A02 Overcomes Tagrisso | Created with Canva

JIN-A02 Overcomes Tagrisso Resistance via C797S and T790M Targeting

ByZachary Zubulake

February 12th 2026

Suzanne Jansen, MSc, PharmD, ICON | Jansen photo courtesy of ICON - created with Canva.

Flexible Formulation Strategies Boost Early-Phase Clinical Success

BySuzanne Jansen, MSc, PharmD

February 12th 2026

Amyloid plaques in Alzheimer's disease | Image Credit: ©Artur -stock.adobe.com

European Biotechs Impacting Treatment of Alzheimer’s Disease

ByCheryl Barton

February 12th 2026

FUJIFILM Biotechnologies Expands in UK | Created with Cavna

Fujifilm Unveils £400m UK Biomanufacturing Expansion

ByZachary Zubulake

February 11th 2026

IMA acquires ProSys | Created with Canva

IMA Group Acquires ProSys to Scale Global Aseptic Sampling Solutions

ByZachary Zubulake

February 11th 2026

Enhancing the Solubility of Poorly Soluble Drugs

Newsletter

Related Content

JIN-A02 Overcomes Tagrisso Resistance via C797S and T790M Targeting

Flexible Formulation Strategies Boost Early-Phase Clinical Success

European Biotechs Impacting Treatment of Alzheimer’s Disease

Fujifilm Unveils £400m UK Biomanufacturing Expansion

IMA Group Acquires ProSys to Scale Global Aseptic Sampling Solutions

Trending on Pharmaceutical Technology

European Biotechs Impacting Treatment of Alzheimer’s Disease

Fujifilm Unveils £400m UK Biomanufacturing Expansion

IMA Group Acquires ProSys to Scale Global Aseptic Sampling Solutions

Takeda and Iambic Partner for AI Small Molecule Discovery

Women in STEM: Unique Impacts in Rare Disease Development